Article Details

PCSK9 Inhibitors Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials ...

Retrieved on: 2023-11-21 17:16:26

Tags for this article:

Click the tags to see associated articles and topics

PCSK9 Inhibitors Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials .... View article details on hiswai:

Excerpt

AZD 8233: AstraZeneca; AK102: Akeso Biopharma; Evolocumab: Amgen; SHR-1209: Jiangsu Hengrui Medicine Co. Tafolecimab: Innovent Biologics; LIB003 ( ...

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up